Sign up for our newsletter and get the latest big data news and analysis.

Leveraging High Quality Data to Discover Drugs

Thomson Reuters IPS

The IP & Science Business of Thomson Reuters has announced a strategic initiative with NuMedii. The companies will leverage high-quality data, knowledge and predictive technologies to identify therapeutic candidates with the greatest probability for clinical success.